Home » Topics » BioWorld Science

BioWorld Science
RSS

4D Pharma gains further clearances to conduct phase II study of Blautix for IBS

June 13, 2018

Bioelectron Technology presents new imidazole compounds

June 13, 2018

CStone initiates pivotal studies of CS-1001 in China

June 13, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

Cynata reports 6-month data from cohort A of phase I trial of CYP-001 in acute GvHD

June 13, 2018

Alexion and Complement partner to codevelop CP-010 for neurodegenerative disorders

June 13, 2018

BridgeBio to acquire ALXN-1101 from Alexion for MoCD type A

June 13, 2018

FDA grants rare pediatric disease designation to A-4250

June 13, 2018

IL18-secreting CAR T cells have improved antitumor activity and promote endogenous immune responses

June 13, 2018

Novel gene therapy for the treatment of Rett syndrome demonstrates efficacy and safety in vivo

June 13, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...